| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00286762 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF00286762.pdf |
| http://link.springer.com/article/10.1007/BF00286762/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/BF00286762 | ||
| P698 | PubMed publication ID | 7652460 |
| P2093 | author name string | H. Kondo | |
| M. Nomura | |||
| J. Okada | |||
| P2860 | cites work | Human Biology | Q2093146 |
| The Journal of Rheumatology | Q7743623 | ||
| Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results | Q93670714 | ||
| Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I | Q28304443 | ||
| Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor | Q28320184 | ||
| Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus | Q28365920 | ||
| Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions | Q28575622 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Immunology and Clinical Importance of Antiphospholipid Antibodies | Q33379907 | ||
| Anti-phospholipid antibodies | Q33458638 | ||
| Antiphospholipid antibodies: new perspectives on antigenic specificity | Q35166294 | ||
| Antiphospholipid Antibodies: Method of Detection | Q35177113 | ||
| Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I | Q35822631 | ||
| Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity | Q36157442 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding | Q41654634 | ||
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
| Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies | Q43464737 | ||
| Amino acid sequence and location of the disulfide bonds in bovine .beta.2 glycoprotein I: the presence of five Sushi domains | Q53780809 | ||
| Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin | Q67866864 | ||
| Antiphospholipid antibodies require beta 2-glycoprotein I (apolipoprotein H) as cofactor | Q67928975 | ||
| Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies | Q67939879 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| The beta-2-glycoprotein I and antiphospholipid antibodies | Q68018469 | ||
| Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levels | Q68033000 | ||
| Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen | Q68042865 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease | Q68091809 | ||
| Apolipoprotein H (beta-2-glycoprotein I) polymorphism in Asians | Q68235920 | ||
| Syndrome of the black swan | Q69418368 | ||
| Standardising the anti-cardiolipin antibody test | Q69893326 | ||
| Similar mechanism of various lupus anticoagulants | Q69944224 | ||
| beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles | Q70479801 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Detection of anti-bovine beta 2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome | |
| Detection of anti-bovine ?2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome | |||
| P478 | volume | 15 |
| Q33501922 | A patient with mixed collagen disease, antiphospholipid syndrome and Sjögren syndrome |
| Q79293606 | Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? |
| Q40651854 | Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies |
| Q41657392 | Separation methods for glycoprotein analysis and preparation. |
Search more.